Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/1613
Campo DC Valor Lengua/Idioma
dc.contributor.authorJiménez Ortega, Vanesaes
dc.contributor.authorCano Barquilla, Pilares
dc.contributor.authorFernández Mateos, María P.es
dc.contributor.authorCardinali, Daniel Pedroes
dc.contributor.authorEsquifino, Ana I.es
dc.date.accessioned2019-05-02T14:01:06Z-
dc.date.available2019-05-02T14:01:06Z-
dc.date.issued2012-
dc.identifier.citationJiménez Ortega, V, et al. Cadmium as an endocrine disruptor. Correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin [en línea]. Preprint del artículo publicado en Free radical biology and medicine. 2012, 53. doi:10.1016/j.freeradbiomed.2012.10.533. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1613es
dc.identifier.issn0891-5849-
dc.identifier.urihttps://repositorio.uca.edu.ar/handle/123456789/1613-
dc.description.abstractAbstract: To examine the effect a low dose of Cd as an endocrine disruptor, male Wistar rats received CdCl2 (5 ppm Cd) in drinking water or drinking water alone. After 1 month, rats were euthanized at one of six time intervals around the clock and the 24-h pattern of adenohypophysial PRL synthesis and release, lipid peroxidation and redox enzyme and metallothionein (MT) gene expression was examined. Cd suppressed 24-h rhythmicity in expression of PRL gene and in circulating PRL by increasing them at early photophase only, in correlation with an augmented pituitary lipid peroxidation and redox enzyme expression. CdCl2 treatment effectively disrupted the 24-h variation in expression of every pituitary parameter tested except for MT-3. In a second experiment the effect of melatonin (3 μg/mL drinking water) was assessed at early photophase, the time of maximal endocrine disrupting effect of Cd. Melatonin treatment blunted the effect of Cd on PRL synthesis and release, decreased Cd-induced lipid peroxidation and counteracted the effect of Cd on expression of most redox enzymes. A third experiment was performed to examine whether melatonin could counteract Cd-induced changes in the 24-h pattern of pituitary circadian clock gene expression and plasma PRL, LH, TSH and corticosterone levels. Rats receiving CdCl2 exhibited a suppressed daily rhythm of Clock expression and a significant disruption in daily rhythms of pituitary Bmal1, Per1, Per2, Cry1 and Cry2. The co-administration of melatonin restored rhythmicity in Clock and Bmal1 expression but shifted the maxima in pituitary Per1, Cry1 and Cry2 expression to the scotophase. Melatonin also counteracted the effect of Cd on 24-h rhythmicity of circulating PRL, LH, TSH and corticosterone. The results underline the occurrence of a significant endocrine disruptor effect of a low dose of Cd. Generally melatonin counteracted the effects of Cd and ameliorated partly the circadian disruption caused by the pollutant.es
dc.formatapplication/pdfes
dc.languageenges
dc.language.isoenges
dc.publisherElsevieres
dc.rightsAcceso Abiertoes
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/es
dc.sourceFree radical biology and medicine. 2012, 53es
dc.subjectCADMIOes
dc.subjectPROLACTINAes
dc.subjectRITMO CARDIACOes
dc.subjectMELATONINAes
dc.subjectEXPRESION GENICAes
dc.subjectCORTICOSTERONAes
dc.titleCadmium as an endocrine disruptor : correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonines
dc.typeArtículoes
dc.identifier.doi10.1016/j.freeradbiomed.2012.10.533-
uca.pathFacultad de Ciencias Médicas|Departamento de Docencia e Investigaciónes
uca.disciplinaMEDICINAes
uca.filename/home/data-uca-generic/folder_generic/IIBiomedicas/cadmium-endocrine-disruptor-correlation/metadata.xmles
uca.issnrd1es
uca.affiliationFil: Jiménez Ortega, Vanesa. Universidad Complutense. Facultad de Medicina. Departamento de Bioquímica y Biología Molecular III; Españaes
uca.affiliationFil: Cano Barquilla, Pilar. Universidad Complutense. Facultad de Medicina. Departamento de Bioquímica y Biología Molecular III; Españaes
uca.affiliationFil: Fernández Mateos, Pilar. Universidad Complutense. Facultad de Medicina. Departamento de Bioquímica y Biología Molecular III; Españaes
uca.affiliationFil: Fernández Mateos, Pilar. Universidad Complutense. Facultad de Medicina. Departamento de Biología Celular; Españaes
uca.affiliationFil: Cardinali, Daniel P. Pontificia Universidad Católica Argentina. Facultad de Medicina. Departamento de Docencia e Investigación; Argentinaes
uca.affiliationFil: Cardinali, Daniel P. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Fisiología; Argentinaes
uca.affiliationFil: Esquifino, Ana I. Universidad Complutense. Facultad de Medicina. Departamento de Bioquímica y Biología Molecular III; Españaes
uca.versionsubmittedVersiones
item.grantfulltextopen-
item.fulltextWith Fulltext-
item.languageiso639-1en-
crisitem.author.deptConsejo Nacional de Investigaciones Científicas y Técnicas-
crisitem.author.deptInstituto de Investigaciones Biomédicas - BIOMED-
crisitem.author.deptFacultad de Ciencias Médicas-
crisitem.author.orcid0000-0002-0813-9088-
crisitem.author.parentorgFacultad de Ciencias Médicas-
crisitem.author.parentorgPontificia Universidad Católica Argentina-
Aparece en las colecciones: Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
cadmium-endocrine-disruptor-correlation.pdf777,28 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

309
comprobado en 18-abr-2024

Descarga(s)

441
comprobado en 18-abr-2024

Google ScholarTM

Consultar


Altmetric


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons